We excel in innovative medicines, but we need to be
Balazs Barabas
We excel in innovative medicines, but we need to be vigilant about keeping generic drug production in Europe. Our Critical Medicine Act aims to: 💊ensure easier access 🇪🇺boost local production 🧪improve supply chain security =more stability for the EU's pharmaceutical industry.
din zilele anterioare